Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer

NCT00003819 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: QS21
BIOLOGICAL: TF(c)-KLH conjugate vaccine
BIOLOGICAL: Thomsen-Friedenreich antigen
BIOLOGICAL: keyhole limpet hemocyanin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]